Shares in Inca Minerals surge 13% as drilling starts at Riqueza

|

Published 20-MAR-2017 15:15 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Inca Minerals’ (ASX code: ICG) announcement on Monday morning that its maiden drilling program at Riqueza had commenced resulted in the company’s shares spiking 13% in the first hour of trading, eclipsing their 12 month high of 2.5 cents.

It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

The start of drilling follows the issue of the official drilling commencement date, a milestone in its own right, but as Managing Director Ross Brown pointed out, since the time the drill permit was lodged ICG has more than quadrupled the number of targets at Riqueza, substantially improving the group’s understanding of the mineralisation.

The parameters of the DIA drilling permit provide ICG with a drilling capacity of 16,800m (14,000m + 20%) and a trench capacity of 3,080m, in Brown’s view representing a sizable allowance that will enable the company to properly investigate the myriad of quality targets that appear concentrated at Riqueza.

Riqueza hosts two related mineral deposits, a zinc-silver-lead replacement deposit at the Humaspunco-Pinta combined prospect area and a zinc-silver-lead-gold deposit at the Uchpanga prospect. Management is of the view that these deposits form part of a large intrusive-related replacement mineral system.

BHP moves in alongside ICG

Providing confidence in ICG’s read of the geological features is the fact that three mines in the near vicinity are intrusive-related replacement deposits, and with BHP Billiton having recently lodged applications for ground directly adjacent to Riqueza, the mining giant must see the prospect of a substantial deposit.

ICG’s list of priority drill targets has increased recently with the firming-up of the 800 metre long Callancocha Structure feeder zone (Callancocha Target) as a major new high priority target. The Callancocha Target adds to the eight kilometres of Zn-Ag-Pb-bearing veins, a conservative estimate of one square kilometre of stacked mantos, and an increasing number of breccias at Humaspunco”.

Explaining ICG’s exploration strategy, Brown said,” DIA trenching and the detailed mapping and systematic sampling program (DMASS) will run as parallel programs at the same time as drilling”.

Management expects assay results from early drilling to be released as early as mid to late April, perhaps providing share price momentum that could see the company continue to rerate.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X